TAM
TFG Asset Management Portfolio holdings
AUM
$554M
This Quarter Return
-0.48%
1 Year Return
+17.58%
3 Year Return
+43.97%
5 Year Return
+47.35%
10 Year Return
+63.64%
AUM
$312M
AUM Growth
+$312M
(+0.62%)
Cap. Flow
+$34.3M
Cap. Flow
% of AUM
10.99%
Top 10 Holdings %
Top 10 Hldgs %
85.07%
Holding
33
New
7
Increased
8
Reduced
3
Closed
1
Top Buys
| 1 |
UiPath
PATH
|
$20.6M |
| 2 |
Informatica
INFA
|
$3.49M |
| 3 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$3.32M |
| 4 |
Annexon
ANNX
|
$2.41M |
| 5 |
Immunovant
IMVT
|
$2.24M |
Top Sells
| 1 |
BigBear.ai
BBAI
|
$4.01M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$2.14M |
| 3 |
Tarsus Pharmaceuticals
TARS
|
$1.11M |
| 4 |
Axsome Therapeutics
AXSM
|
$868K |
Sector Composition
| 1 | Technology | 44.21% |
| 2 | Energy | 19.21% |
| 3 | Healthcare | 15.75% |
| 4 | Materials | 0.61% |
| 5 | Consumer Staples | 0.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UiPath
PATH
$5.95B
| $92.2M | 21.04% | 8,950,000 +2,000,000 | +29% | +$20.6M |
|
|
KGEI
2
Kolibri Global Energy
KGEI
$200M
| $59M | 13.47% | 7,070,568 | – | – |
|
3
Sprinklr
CXM
$2.24B
| $18.4M | 4.19% | 2,200,000 | – | – |
|
|
4
Informatica
INFA
$7.6B
| $14M | 3.19% | 800,000 +200,000 | +33% | +$3.49M |
|
|
AUTL
5
Autolus Therapeutics
AUTL
$399M
| $13.3M | 3.04% | 8,600,000 +350,000 | +4% | +$543K |
|
6
Lyft
LYFT
$6.73B
| $11.9M | 2.71% | 1,000,000 | – | – |
|
|
7
Tarsus Pharmaceuticals
TARS
$2.47B
| $9.17M | 2.09% | 178,470 -21,530 | -11% | -$1.11M |
|
|
8
Annexon
ANNX
$226M
| $5.11M | 1.17% | 2,650,000 +1,250,000 | +89% | +$2.41M |
|
|
9
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $4.98M | 1.14% | 63,142 -27,185 | -30% | -$2.14M |
|
10
Celldex Therapeutics
CLDX
$1.47B
| $4.74M | 1.08% | 261,000 +69,000 | +36% | +$1.25M |
|
|
11
Axsome Therapeutics
AXSM
$6.05B
| $3.94M | 0.9% | 33,806 -7,444 | -18% | -$868K |
|
|
TECX
12
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $3.32M | 0.76% | +187,500 | New | +$3.32M |
|
|
13
Immunovant
IMVT
$2.56B
| $2.24M | 0.51% | +131,167 | New | +$2.24M |
|
14
Pharvaris
PHVS
$1.39B
| $1.99M | 0.46% | +126,995 | New | +$1.99M |
|
15
Keros Therapeutics
KROS
$618M
| $1.86M | 0.43% | 183,000 +80,000 | +78% | +$815K |
|
16
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.78M | 0.41% | +107,000 | New | +$1.78M |
|
17
Relay Therapeutics
RLAY
$619M
| $1.62M | 0.37% | +619,000 | New | +$1.62M |
|
18
Snowflake
SNOW
$79.6B
| $1.46M | 0.33% | 10,000 | – | – |
|
19
Cameco
CCJ
$33.7B
| $877K | 0.2% | +21,300 | New | +$877K |
|
20
Compañía de Minas Buenaventura
BVN
$4.86B
| $867K | 0.2% | 55,500 +18,500 | +50% | +$289K |
|
21
Hudbay
HBM
$4.75B
| $812K | 0.19% | 107,000 +49,000 | +84% | +$372K |
|
|
OTLY
22
Oatly Group
OTLY
$533M
| $798K | 0.18% | +81,210 | New | +$798K |
|
23
Teck Resources
TECK
$16.7B
| $232K | 0.05% | 6,368 | – | – |
|
24
Diana Shipping Inc. Warrants to Purchase Common Stock (expiring on or about December 14, 2026)
DSX.WS
$15.1M
| $32.9K | 0.01% | 301,800 | – | – |
|
25
Sonder Holdings Inc. Warrants
SONDW
$129K
| $130 | ﹤0.01% | 18,898 | – | – |
|